Nessan Bermingham
2017
In 2017, Nessan Bermingham earned a total compensation of $11.3M as Former President and Chief Executive Officer at Intellia Therapeutics, a 181% increase compared to previous year.
Compensation breakdown
| Bonus | $324,002 |
|---|---|
| Option Awards | $9,896,380 |
| Salary | $524,846 |
| Other | $529,497 |
| Total | $11,274,725 |
Bermingham received $9.9M in option awards, accounting for 88% of the total pay in 2017.
Bermingham also received $324K in bonus, $524.8K in salary and $529.5K in other compensation.
Rankings
In 2017, Nessan Bermingham's compensation ranked 507th out of 14,666 executives tracked by ExecPay. In other words, Bermingham earned more than 96.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 507 out of 14,666 | 97th |
Division Manufacturing | 163 out of 5,770 | 97th |
Major group Chemicals And Allied Products | 39 out of 2,074 | 98th |
Industry group Drugs | 28 out of 1,730 | 98th |
Industry In Vitro and In Vivo Diagnostic Substances | 1 out of 72 | 99th |
Source: SEC filing on April 17, 2018.
Bermingham's colleagues
We found three more compensation records of executives who worked with Nessan Bermingham at Intellia Therapeutics in 2017.